Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H17Cl2NO3 |
Molecular Weight | 366.238 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1CN(CC2=CC=C(OCC3=CC(Cl)=C(Cl)C=C3)C=C2)C1
InChI
InChIKey=WAAWETUDFSIYSD-UHFFFAOYSA-N
InChI=1S/C18H17Cl2NO3/c19-16-6-3-13(7-17(16)20)11-24-15-4-1-12(2-5-15)8-21-9-14(10-21)18(22)23/h1-7,14H,8-11H2,(H,22,23)
Molecular Formula | C18H17Cl2NO3 |
Molecular Weight | 366.238 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q9H228 Gene ID: 53637.0 Gene Symbol: S1PR5 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/26509640 |
6.0 nM [IC50] |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:30:18 GMT 2023
by
admin
on
Sat Dec 16 17:30:18 GMT 2023
|
Record UNII |
3QLJ2AZ8GW
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1240308-45-5
Created by
admin on Sat Dec 16 17:30:19 GMT 2023 , Edited by admin on Sat Dec 16 17:30:19 GMT 2023
|
PRIMARY | |||
|
DTXSID301045800
Created by
admin on Sat Dec 16 17:30:19 GMT 2023 , Edited by admin on Sat Dec 16 17:30:19 GMT 2023
|
PRIMARY | |||
|
3QLJ2AZ8GW
Created by
admin on Sat Dec 16 17:30:19 GMT 2023 , Edited by admin on Sat Dec 16 17:30:19 GMT 2023
|
PRIMARY | |||
|
46872626
Created by
admin on Sat Dec 16 17:30:19 GMT 2023 , Edited by admin on Sat Dec 16 17:30:19 GMT 2023
|
PRIMARY | |||
|
A-971432
Created by
admin on Sat Dec 16 17:30:19 GMT 2023 , Edited by admin on Sat Dec 16 17:30:19 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|